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Abstract
We have become familiar and comfortable with the idea that the science, technology and innovation (STI) system of
countries is constructed around the so called ?triple helix? of government, universities and business. Contrary to the
academic interest and government policy, the public is increasingly bypassing this club to impact science funding and
innovation outcomes through directly creating and donating funds for research that they want. The charities and
foundations coordinating this shift are neither ignorant of strategy or dealing in petty cash. In a significant number of
OECD countries, private-non-profits as the statistical category is called, fund the higher education research system at a
similar or greater level than business. This result has important implications for how we understand the STI system. This
paper explores this gap in the literature, ambiguities in analyzing the phenomenon and suggests a framework for further
analysis how charities and foundations are reconfiguring STI systems.
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Abstract 
 
We have become familiar and comfortable with the idea that the science, technology and 
innovation (STI) system of countries is constructed around the so called Òtriple helixÓ of 
government, universities and business. Contrary to the academic interest and government policy, 
the public is increasingly bypassing this club to impact science funding and innovation outcomes 
through directly creating and donating funds for research that they want. The charities and 
foundations coordinating this shift are neither ignorant of strategy or dealing in petty cash. In a 
significant number of OECD countries, private-non-profits as the statistical category is called, 
fund the higher education research system at a similar or greater level than business. This result 
has important implications for how we understand the STI system. This paper explores this gap 
in the literature, ambiguities in analyzing the phenomenon and suggests a framework for further 
analysis how charities and foundations are reconfiguring STI systems. 
 
1. Introduction 
According to Statistics Canada (2013), in 2012 Ðrtkxcvg-non-rtqhkvÑ" kpuvkvwvkqpu." yjkej" ctg"
wuwcnn{"vjqwijv"qh"cu"Ðejctkvkgu"cpf"hqwpfcvkqpu1Ñ"*E(Hu+"funded about 3.5 per cent of R&D in 
Canada, the highest point since the beginning of R&D statistics in the early 1960s. Contrast this 
with the provinces that contribute about 5% of GERD while the Canadian Institutes of Health 
Research (CIHR) is 3.5% of the total. More striking is that C&Fs fund more research in the 
universities than the business sector. As we show in section three (below) this is not exceptional 
in OECD countries. C&Fs appear to be a fast growing R&D funding sector in the Canadian 
economy. Furthermore contributions from C&Fs apparently have a strong influence on funding 
decisions made by others, particularly the federal granting agencies.  
Given the number of health charities, particularly those that involve the general public through 
participatory events such as walks, runs, cycle-thons, (coupled with the associated media 
coverage) that result in donations to disease/condition specific research funds this topic should 
surely be one of interest to investigators focussed on the governance of research systems. But 
surprisingly, the entire non-profit sector, not just the health C&Fs community, has been largely 
overlooked for its role in national research systems. Nason (2007: 16) in a commentary on the 
Canadian medical research system expresses tjg"ncem"qh" kpvgtguv"ygnn"Ðcs the not-for-profit and 
international sectors are small in terms of funding within the Canadian health research system, 
vjg{"yknn"pqv"dg"eqxgtgf"kp"fgvcknÑ0 Leaving aside the poor analysis for the moment, contrast that 
assessment with PicardÓu (2010) reporting that shows that in a recent poll of Canadians a very 
                                                 
1 A defineable subset of the broader category of non-governmental organisations.  Statistics Canada and other 
countries in the OECD use the term Ðprivate, non-rtqhkv"qticpk¦cvkqpuÑ solely for research activities. 
high percentage supported increasing support for health and medical research. It seems support, 
is not merely a wish but acted upon out of their own wallets (see Fig 2 for time series from 1996-
2010). There therefore  a powerful dissonance between the public and policy discourses. 
Science, technology and innovation studies have focussed on the role of the three institutional 
silos of business, government (funding and labs) and universities. Tjg"rwdnkeÓu" kpxqnxgogpv"as 
stakeholders in setting research priorities has been overlooked. Their money donated to a C&F 
for research, whether for health or other research (for example, endangered species), represents a 
direct expression by members of the public of what they wish to see as research priorities. 
Within the modern research system that has evolved in Canada other OECD countries; what is 
the role of the non-profit sector, and why do they succeed in some but not all countries? How 
much influence do they have on the allocation of research resources? 
This paper can not address all these fundamental questions. With the overall lack of landmarks 
our work is focussed on creating a set of Òroad mapsÓ vq"vjg"ugevqtÓu"kpxqnxgogpv"kp"vjg"tgugctej"
sector, both where it directs its funding and how it tries to tilt the playing field in its interests 
while others attempt to do the same in other directions. The key point behind this paper is to 
show first that the non-profit sector in some countries is a significant and growing funder of 
research, second to highlight the complex relations between the organisations and the science, 
technology and innovation systems of nations and third to map out some important research 
questions for focussed future work. 
2. Literature 
In searching through academic literature in research policy, industry and innovation and 
equivalent journals there are few papers that focus on the role of private non-profits as the 
Frascati manual (OECD 2002) calls charities and foundations. In the early 1970s the OECD 
published a three volume synthesis of the state of knowledge on the STI systems of member 
countries. This document in part reported:  
At first sight it is not easy to grasp how these foundations fit into the research system. 
It is hard to see what objectives even those that are world famous have set 
vjgougnxgu"cpf"yjcv"ghhgevkxg"rctv"vjg{"rnc{"kp"hwtvjgtkpi"tgugctej0"È"Yjcv"hwvwtg"
can they have, now that the euphoria of the of the post Îwar years is over, when it is 
common knowledge that research costs nowadays are mounting ever higher, and that 
even the vast resources of a national budget are no longer adequate? Has the era of 
private research come to end? And if there is still an independent sector, is it not 
wasteful to allow programmes which are bound to be costly to escape national 
planning at a time when we seem to be entering a period of scarcity (Flory 
1973:162)? 
Roughly 30 years later, in the early 2000s the OECD published a similar three volume work 
which curiously did not appear to acknowledge its predecessor. The governance of innovation 
systems (2005) essentially ignored the non-profit sector. Therefore, today in sum, we know the 
answer to only one of the question posed by Flory Î the non-profit foundations sector has 
boomed and not disappeared, but beyond this we know little more. The other questions (implied 
and otherwise) have gone unanswered. 
The phenomenal growth of charities focused on funding research has not escaped attention 
completely. In this paper we need to cross a boundary and integrate the broad domain of 
mainstream STI policy and neo-Schumpeterian economics (Winter 2006) with that of Òuekgpeg"
and technology studiesÓ which focuses on the sociology of science and technology activity. 
Though these two broad domains are often interested in similar phenomenon their methodologies 
and perspectives differ and it seems fewer and fewer researchers in either field are aware of the 
other anymore. The gap between these fields is best emphasised by Hackett et.al.: 
The Handbook of Science and Technology Studies is the third in a series of volumes 
sponsored by the Society for Social Studies of Science that have defined the field of 
Science and Technology Studies. It will be an essential resource for scholars in S&TS as 
well as for those in such neighboring disciplines as anthropology, history, philosophy, 
sociology, law, political science, feminist and critical theory, and literary studies 
(emphasis added, the back cover, 2009). 
Literary studies, it seems is a closer relation academically to STS than neo-schumpeterian 
scholars investigating the science and technology system. However, it is in STS that there has 
been serious investigation of the rise of Òpatient groupsÓ" cu" vjg{" jcxg" dggp" vgtogf. We could 
characterise the present the structure of the research related to charities and foundations as in 
Fig1. 
 
 
Business as usual Î the exogeneity of society  
Science, technology and innovation studies have focussed on the role of the three institutional 
silos of business, government (funding and labs) and universities. Whether it is the University-
Industry relations concerns of the 1970s, 1980s and early 1990s (see Abelson 1974, Brown and 
QÓDtkgp" 3;:3" qt"Ocpuhkgnf" 3;;3+ or its successor the work that falls under the rubric of the 
Òtriple helixÓ (Etzkowitz and Leydesdorf 2000) Î where Òvjg"gxqnwvkqp"qh"kppqxcvkqp"u{uvgou."cpf"
the current conflict over which path should be taken in universityÎindustry relations, are 
reflected in the varying institutional arrangements of universityÎindustryÎiqxgtpogpv"tgncvkqpuÓ"
(2000: 111), the interest is in institutional frameworks. These sectors reflect the major sectors of 
knowledge creation Îrepresenting a formal perspective on funding and prioritisation. These same 
authors astutely acknowledged that the public was missing from their model and wanted to 
acknowledge it. 
ÐVtgcvkpi"vjg"rwdnke"cu"ogtgn{"c"hqwtvj"jgnkz"fgpkgu"kv"dgkpi"vjg"hqwpfcvkqp"qh"vjg"
enterprise of innovation: the ability of individuals and groups to organize freely, to 
debate, and take initiatives without state permission is fundamental to the concept of 
vjg"Vtkrng"JgnkzÈÈ0"Qpg"ogejcpkuo"hqt"vjku"ku."kp"qwt"qrkpkqp."vjg"igpgtcvkqp"qh"
public demand for innovationÑ (Leydesdorff and Etzkowitz 2003: 57/58) 
Boon et.al. (2011) takes up this issue of demand for innovation and new technologies from the 
rqkpv"qh"xkgy"qh"Òkpvgtogfkct{"qticpkucvkqpuÓ0"Yjkng"vjg"rcrgt"ftcyu"cvvgpvkqp"vq"ugxgtcn"rcvkgpv"
groups their positioning of these groups within UVK"ku"wpengct0"Vjgug"Òkpvgtogfkct{"itqwruÓ"eqog"
cetquu"cu"tgncvkxgn{"ygcm"cpf"kp"cp"codkiwqwu"rqukvkqp"tgncvkxg"vq"qvjgt"rnc{gtu0"ÒKntermediariesÓ"
is an unclear term, at best. In the literature it has been variously defined but includes that of 
bridging organisations on the way to market or as Dalziel (2010) does Òinnovation intermediaries 
as organizations or groups within organizations that work to enable innovation, either directly by 
enabling the innovativeness of one or more firms, or indirectly by enhancing the innovative 
capacity of regions, nations, or sectorsÓ. In focusing on a broad range of types of organisations 
that are non-business, non-government organisations this definition lacks a focus on the 
particularities of charities.  
 
Related to this discussion, but distinct is the term democratisation which has emerged in 
connection with user developed innovation (see Von Hippel 2001 and 2005). ÒWhen I say that 
innovation is being democratized, I mean that users of products and servicesÏboth firms and 
individual consumersÏare increasingly ablg"vq"kppqxcvg"hqt"vjgougnxguÓ"(2005:1). Alternatively, 
the democratisation of science (Kleinman 1998+."ku"fghkpgf"cu"vjg"rwdnkeÓu"kpxqnxgogpv"kp"vjg"
analysis and acceptance of technologies (particularly controversial technologies such as 
biotechnology). In their introduction to a special issue on democratisation of science, Griessler et 
al. introduce the topic this way: 
The perceived democratic deficit at national and EU levels is a much discussed and 
lamented policy problem of our times. Citizens, policy-makers and social scientists often 
call for citizen participation in policy analysis or decision- making for reasons of 
democratic legitimacy and effectiveness. In the field of science and technology policy calls 
for increased citizen participation have gained strength over the last two to three decades, 
in part in response to a series of dramatic public controversies (e.g. nuclear energy, BSE, 
genetically modified organisms (GMOs), and human embryonic stem cell research) 
(2011:583 ) 
However, all these approaches to the missing public have understood the public as being in a 
relatively weak position, as the tail on the dog. However, increasingly the public is being more 
assertive that this and actively engages with the system through favoured charities. With serious 
money comes the power to drive the STI system. This is not lost on the C&Fs and because of the 
very rgtegrvkqp"qh"dgkpi"qp"vjg"tgegkxkpi"gpf"qh"qvjgtuÓ"rtkqtkvkgu"many C&Fs are formed to 
explicitly influence the direction of research (the strategies are discussed below in section 4).  
 
The rise of patient groups and disease/conditions C&Fs 
It would be valuable to have data and studies on a wide spectrum of C&Fs acting in the research 
system so that taxonomies could be presented and analysed, but unfortunately there are large 
gaps in our knowledge. The exception to this is that there is a significant body of research on so 
ecnngf"Òrcvkgpv"itqwruÓ0"Epstein (2009) positions this topic within the broader research on interest 
groups and social movements which is massive. Nevertheless in STS the research on patient 
groups covers an expansive range of topics. We are focussed on the engagement of patient 
groups with the research system but as this is not the sole or even prime focus of the STS 
material some of the context will be discussed here. 
To make the case that C&Fs are strong enough to engage with traditional STI systems players, it 
is worthwhile showing that patient groups have been influential in the very identity and 
definition of diseases and conditions. It seems strange to think that diagnoses and treatments may 
vary between OECD countries but this is the case. One interesting example that highlights the 
role and strength of patient groups and their associated organisations and research funding is that 
of Tourette syndrome. ÒIknngu"fg"nc"Vqwtgvvg"u{pftqog"ku"c"fkuqtfgt"kp"yjkej"vjg"chhgevgf"rgtuqp"
display a sudden array of rapid, recurrent, non-tj{vjoke."cpf"uvgtgqv{rgf"oqvqt"cpf"xqecn"vkeuÓ"
(Kushner 2004: 72). The condition is called a syndrome because there is not yet a clinical 
etiology (cause/origin) and therefore its diagnoses relies upon doctors comparing a list of defined 
characteristics against a patient and determining whether a particular patient has enough 
evidence of the syndrome to warrant diagnoses.   
Prior to the 1970s the condition was almost universally attributed to psychogenic causes (in the 
mind) but in the USA starting in the 1960s a patient group emerged that pushed for and funded 
research that sought evidence of a biological cause. Today in the USA and Britain (and by 
implication other anglo countries) the diagnoses of Tourette is not uncommon. The range is from 
around 0.04% to 5% of the population; with boys 4 times more likely than girls to be diagnosed 
with the condition (Kushner 2004:72). In these countries the etiology is thought to be based in 
genetic, biochemical or infections. However, in France there is virtually never a diagnosis of 
Tourette syndrome because the physicians there are convinced of the view of psychogenic 
origins (behaviours Î bad habits, psychoanalytic Î early childhood conflicts etc [Kushner 
2004:76]). There has never been a strong patient group emerge in France.  
So here is a case of a patient group emerging onto a national scene (the USA first) that was 
intimately involved in the actual definition of a condition through activism and research funding. 
Thus patient groups can help shape the very trajectory of research and what is the predominantly 
accepted view in a particular country and the lack of a patient group also shapes national medical 
culture. The medical establishment in France unchallenged continues in the view it had before 
the changes elsewhere in the world. We make no observation here as to which view of the 
condition is correct.  
While many specific C&Fs may not have long histories, patient groups for a large range of 
conditions have existed for decades Î dating back to at least the 1950s and 1960s. Why then was 
there such a rise in their profile and money raising abilities of them during the 1990s, such as 
there was (see Section 3 below). There is no apparent single cause, but three important events 
seem to have coincided. Callon (2003) brings together two of them. The ÒCold War institutional 
ConfigurationÓ, as he calls it, dominated the public model of political discourse until the late 
1980s. As the fear of a devastating war diminished, the public became more emboldened to get 
other issues on national agendas. Secondly, the activism of the AIDS movement that formed in 
the 1980s seems to have been instructive to other groups and taught them lessons for interacting 
with institutional players and publics (see also Epstein 2009). The third factor is that of cut backs 
in government services in the USA (perhaps elsewhere as well) and the push to make the public 
more self-reliant (Eikenberry (2006); occurring as this did in the 1980s it was concurrent with 
the evolution of the other two factors. 
Although, these appear to be the fertile soil for change it was the breast cancer movement in the 
USA that appears to have revolutionised C&F strategies. Many articles (see e.g. King 2006) 
document the rise of the breast cancer movement from a relatively weak group (Halebsky 2003) 
to one that resonated with the public (Kolker 2004) and moved the condition from Òa stigmatized 
disease best dealt with privately and in isolation, to a neglected epidemic worthy of public debate 
and political organizing, to an enriching and affirming experience during which women with the 
fkugcug" ctg" tctgn{" ÒrcvkgpvuÓ" cpf" oquvn{" Òuwtxkxqtu0Ó" *Mkpi" 2004). In this journey key 
organisations have created `causumerism' as most visible through the pink ribbon campaigns 
(Ponte and Richey 2011). 
Despite, this vast body of work, the organisational strategies and their role in the mainstream 
science funding system is opaque. The STS literature being based in the sociological disciplines 
has taken only a small interest in the strategic operations of the patient movement organisations. 
The focus has been much more on the socio-political causes and consequences of the particular 
orientation of a particular organisation in a particular country.  
Even in obvious opportunities to articulate the importance of charities and patient groups in the 
STI system the articles miss their mark. Take for example Callon (2003), in a book about 
research funding his chapter dealt with the patient movements in a way that focuses on small 
obscure examples rather than communicating clearly on the overall scale and strategic activities 
of patient groups and C&Fs. Rabeharisoa and Callon (2002) describe in some detail the history 
of the Association francaise contre les Myopathies (French muscular dystrophy association) and 
also detail the complexities of  its interactions with the Centre National de la Recherches 
Scientifiques (CNRS) but details on the importance of funding are absent. More recently Callon 
and Rabeharisoa use actor network theory to articulate some of the strategies of the Association 
francaise contre les Myopathies but do not generalise them to a wider perspective on the 
interactions between charities and the STI system. None of the studies that do address the role of 
the patient organisations indicate the scale of national funding or its direction.  
 
Thus, the STS literature does not address itself to engagement with the STI system and the STI 
literature ignores the rise of the charities. Our first goal then in this paper is to establish a map to 
the role charities play in the science and research system. 
 
3. Data Analysis: How important is the C&F sector 
 
Before delving into the data it is important to discuss the technical details of R&D data 
collections. Vjg"QGEF"ÐHtcuecvk"OcpwcnÑ."qtkikpcnn{"fgxgnqrgf"kp"3;85."fghkpgu"jqy"oquv"
developed economies collect data on R&D activities. When the structure was developed for the 
manual there were vastly fewer organisations involved in the science and innovation system so 
the statistical system that emerged focussed on surveying organisations that perform research. 
These organisations can then be asked to identify from whom funds to conduct the research and 
development came from, allowing the data to be simplified as own funds (intramural) or 
extramural from any of business, government, universities, overseas or private non-profits. For 
the most part this approach has worked quite well over the decades (for details see OECD 2002). 
Nevertheless, the system does have weaknesses, revealed by when an organisation is established 
to provide funds for R&D but whose funds may be channelled through other agencies before 
they get to those doing the research, such as the case with charities and foundations. Statistics 
Canada, as one example, collects data from the C&Fs directly, but because this is a survey of the 
C&Fs that are suspected of spending money on research results should in general be considered a 
low estimate. 
 
As a source of funds, this sector covers R&D financed by [not-for-profit institutions] NPIs 
serving households (NPSH). These provide individual or collective services to households 
either without charge or at prices that are not economically significant. Such NPIs may be 
created by associations of persons to provide goods, or more often services, primarily for the 
benefit of members themselves or for general philanthropic purposes. Their activities may be 
financed by regular membership subscriptions or dues or by donations in cash or in kind from 
the general public, corporations or government. They include NPIs such as professional or 
ngctpgf"uqekgvkgu."ejctkvkgu."tgnkgh"qt"ckf"cigpekgu."vtcfgu"wpkqpu."eqpuwogtuÓ"cuuqekcvkons, etc. 
By convention, this sector includes any funds contributed directly to R&D by households. 
 
As a sector of performance, PNP includes non-market units controlled and mainly financed by 
NPIs serving households, notably professional and learned societies and charities, other than 
those providing higher education services or administered by higher education institutions. 
However, R&D foundations managed by NPSH but having more than 50% of their running 
costs covered by a block grant from government should be included in the government sector.  
È 
The following types of PNP organisations should be excluded from this sector: 
 Î Those mainly rendering services to enterprises. 
 Î Those primarily serving government.  
Î Those entirely or mainly financed and controlled by government.  
Î Those offering higher education services or controlled by institutions of higher education 
(OECD 2002:65-66) 
 
This definition needs to be understood with care. In Canada at least a number of large 
government funded organisations both at the federal and provincial levels, for administrative 
reasons have been established as legal non-profit entities. If the statistics are processed 
accurately while these are non-profits they should not appear as PNPs in research funding data. 
 
Table 1 provides PNP data on OECD countries for 10 year intervals starting in 1981. 
 
Table 1: PNP funding as a percentage of GERD Î OECD countries 

   

   ょ
    
    
    
    
    
    
    


  
    

  

    

 
 

 
 
    


  
    

 
 


  
    
    


  
    
    
Source: OECD 2010. 
Notes: ょに 
 
In five OECD countries, the PNP sector of funding accounts for more than three percent of 
GERD.  However, at three percent of GERD, perhaps the lack of attention is warranted. This is a 
small share of the overall effort of countries in creating new knowledge and thus, though 
interesting, relatively low in importance. If we look more closely at some of these examples we 
can examine the dollar amount increases (Table 2). Australia has been included here as its data is 
very accessible and it should be noted that there is a discrepancy between the national data and 
the OECD tables. 
Table 2: Funding of Private Non-Profit Sector (national currency, current dollars) 
Country 1990s 2000s % Increase Latest % 
GERD 
Australia $ 101m (1992-93) $ 606m (06-07) 600 % 3.2 (2006-07) 
Canada $ 272m (1992) $ 835m (07) 306 % 2.9 (2007) 
UK £ 336m (1990) £ 1,154m (07) 343 % 5% (2007) 
USA $ 2,589m (1990) $ 10,593m (07) 409 % 2.8% (2007) 
Sources: Australia: Australian Bureau of Statistics (2008), Canada: Secretariat for Science and Technology Review 
1994) and Industry Canada 2009), UK http://www.dius.gov.uk/~/media/publications/I/Internet-version-SET-
Statistics-Nov-2009-v2 accessed 11 Feb 2010, USA - National Science Board (2010) appendix table 4-3.  
 
These dollar amounts, given that they were raised from the public reveals a dramatic rise. But it 
is when we focus on university research funding that we find something totally surprising (Table 
3). 
 
Table 3: `Comparison Business v PNP funding of HERD Î OECD countries 
 1981 1990 2000 2007 2008 2009 2010 
Australia Business 1.44 2.24 4.88  5.86   
Australia PNP 2.65 5.51 3.38  2.03   
Austria Business 1.02   5.74    
Austria PNP 0.32   1.03    
Canada Business 4.08 4.98 9.55 8.54 8.55 8.54  
Canada PNP 6.63 6.13 7.22 8.74 8.73 8.73  
Denmark Business 0.67 1.57 2.03 2.13  4.44  
Denmark PNP 1.58 4.60 4.75 10.88  7.72  
Finland Business 2.13  5.57 7.00 7.21 6.39  
Finland PNP 2.11  1.17 2.47 3.45 3.35  
France Business 1.33 4.86 2.70 1.63 2.15   
France PNP 0.12 0.08 0.29 0.38 0.75   
Germany Business 1.77 7.89 11.63 15.46 15.14   
Germany PNP        
Hungary Business  22.66 5.47 13.70 14.65 15.52  
Hungary PNP   1.02 1.81 1.88 2.38  
Ireland Business 7.14 10.23 5.33 2.27 3.05 3.50  
Ireland PNP 2.64 1.37 2.65 6.06 5.31 1.57  
Italy Business 2.69 2.38  1.35 1.13 1.03  
Italy PNP    1.08 1.10 1.50  
Japan Business 0.98 2.32 2.50 3.03 2.99   
Japan PNP 0.05 0.11 0.16 1.02 1.09   
Korea Business   15.89 14.15 12.02   
Korea PNP   0.65 0.98 1.02   
Mexico Business   2.03 1.34    
Mexico PNP   0.21 0.03    
Netherlands B 0.26 0.87 7.03 7.47    
Netherlands PNP 2.34 2.19 7.69 9.00    
New Zealand B  4.60  3.11    
New Zealand PNP  6.09  3.42    
Norway Business 2.87   4.03    
Norway PNP 2.00   2.69    
Poland Business   7.85 11.34 3.85 3.32  
Poland PNP   0.69 0.42 0.27 0.18  
Portugal Business  0.70 0.99 1.39 0.92   
Portugal PNP  0.82 2.20 0.76 0.71   
Spain Business 0.00 8.94 6.91 9.01 8.82   
Spain PNP 0.00 0.52 0.98 1.16 0.95   
Sweden Business 2.28   4.92  4.47  
Sweden PNP 3.55   9.20  9.40  
Switzerland 
Business 9.52  5.12  6.85   
Switzerland PNP   2.25  0.25   
UK Business 2.80 7.58 7.10 4.54 4.60 4.60 4.60 
UK PNP 4.92 9.56 16.39 13.50 13.93 13.93 13.93 
USA Business 4.43 6.88 7.08 5.61 5.68   
USA PNP 6.53 7.37 7.58 7.55 7.87   
Source: OECD 2010. 
Notes ÎGermany - From 1991 the data for the Private Non-Profit sector have been included in the Government 
sector 
 - funding calculated as percentage of total HERD funding 
 
In eight OECD countries PNPs fund more research in the university system than business. If we 
follow the trend for a single country (Canada) we can see just how much the spending power of 
the PNPs has risen through the 1990s and 2000s. 
 
Figure 2: Canadian higher education research funding 1996-2010 (excl Fed funds) Î Current $ 
 
Data source Statistics Canada 2011. 
Using detailed Australian data we can calculate where the funding is directed. The Australian 
Bureau of Statistics (ABS) has published detailed fields of research data from which  we see 
strengths both in the biological sciences and health sciences. More intriguing is the expenditure 
on social sciences, is that for health related as well, the data cannot tell us. 
 
 
 
 
Table 4: Private Non-Profit Funding of Research Fields: Australia 2007 
 
2000Î01 2002Î03 2004Î05 2006Î07 
Research field $'000 $'000 $'000 $'000 
Mathematical sciences 
   
443 
Physical sciences 617
 
0 99 
Chemical sciences 2,800 4,045
  Earth sciences 0 0 
 
0
Biological sciences 77,942 104,560 92,230 97,695 
Information, computing &  
         communication sciences 3,105 4,844 1,730 929 
Engineering & technology 410 1,465 
 
1,866 
Agricultural, veterinary & 
        environmental sciences 
 
2,087 
 
2,230 
Architecture, urban environment & 
      building 0 
 
0 0 
Medical & health sciences 185,393 220,796 346,063 457,888 
Education 14,241 
   Economics 131 101
 
255
Commerce, management, tourism & 
      services 
 
53 103 219 
Policy & political science 287 632 
 
1,584 
Studies in human society 671 1,206 2,096 2,087 
Behavioural & cognitive sciences 474 933 1,516 3,353 
Law, justice & law enforcement 
  
0 
 Journalism, librarianship etc 0 0 0 0
The arts 
 
0 0 
 Language & culture 0 0 0 
 History & archaeology 0 0 22 0
Philosophy & religion 66 129 240 206 
Total 289,038 359,548 478,861 606,337 
Source Australian Bureau of Statistics (2008) 
Remembering this probably underestimates nationally, it also ignores the increasing potential for 
large cross border flows from foundations such as the Wellcome Trust and the Bill and Melinda 
Gates Foundation, for which we have little data2. We clearly need more data on this important 
sector.  
One dimension that is clearly missing is the ability to classify funding by diseases and conditions 
so that funding could be compared with rates of conditions in the population. Epstein notes that 
there is likely a correspondence between conditions and the emergence of a patient group but the 
association is unclear: 
the rapid rise of the social response to an emerging illness may depend on a range of 
factors, including the epidemiological significance of the condition, the availability of an 
                                                 
2 However, existing data suggests it is still small (Statistics Canada 2010). 
unequivocal diagnostic test, the social class of the sufferers, the degree of activism, and the 
extent of media coverage (2009: 516). 
There are other important questions regarding the data. Importantly, there are no estimates of 
leverage. Because much of the funding of the C&Fs are channelled through the existing 
institutional system through partnerships with the granting councils and directed towards basic 
science in universities the perceived role of the C&Fs is obscured. It is impossible to measure the 
+ factor here. Obviously, the overall amount of government funding remains the same but what 
role does the strength of particular charities play in pushing money in one direction or another. 
This then goes to the heart of strategizing in this environment which we cover in the next section. 
4. STI system re-configuration Î the SO-ANT framework 
This project is aimed at exploring the role of PNPs in the reconfiguring the overall structure STI 
system. Our research approach has thus been to accumulate evidence of examples which appear 
in the existing literature, websites and media in order to build a framework for further more 
comprehensive research on the intermidate role charities are playing in funding and mobilising 
research. That methodology will need to incorporate the strategies of PNPs other than medical 
(patient group) based charities but for now the most comprehensive evidence exits there.  
Conventional strategy research is not easily summarised but Hoskisson et al. (1999) emphasise 
that research has swung between accentuating the internal aspects of the organisation 
(leadership, organisational structure and more recently the resource based view), external factors 
(industry structure, environmental fit etc) and the space in between (transaction costs especially 
firm and market boundaries etc). There is no doubt that this research can be applied to non-profit 
organisations (see Moore 2000). However, we take the view that this literature is difficult to use 
for our purpose. Specific sub-fields of strategy (see e.g. Mintzberg et al. 1998), environmental fit 
(Dess and Beard), resource based view (Barney 1991), and dynamic capabilities (Teece 2007) do 
not capture the dynamics we want to emphasise. 
The strategy literature takes as its core starting points either the success of individual firms 
within an industry or the industry itself. Primarily, we are not interested in the success 
dynamics of individual charities as they compete against one another. We are interested in 
how charities and foundations generically have succeeded in changing the science funding 
ÒoctmgvÓ0 Vjku"ceeqtfu"oquv"pgctn{"vq"vjg"itqykpi"Òkpfwuvt{"ctejkvgevwtgÓ"nkvgtcvwtg"*Lceqdkfkgu"gv"
cn0"4228+."{gv"vjgtg"ku"pq"uvcpfctfkugf"crrtqcej"vq"ocrrkpi"uwej"ÒctejkvgevwtguÓ0 
Secondly in this study the structure of science funding markets are understood as relatively rigid, 
similar across many countries and do not change quickly. This provides very special conditions. 
Therefore we focussed on the changing structure of the funding market. Further, as we 
increasingly understand that economies and organisations are usefully represented as complex 
networks (Kilduff and Bass 2010) we wish to capture these issues. Lastly, the STS literature in 
already adopting a framework based on a constructivist network premise in its analyses of the 
jkuvqtkgu"qh"rcvkgpv"itqwru"kv"ku"jctfgt"vq"ÒhkvÓ"vjg"fcvc"cpf"gxkfgpeg"kpvq"c"eqpxgpvkqpcn"uvtcvgike"
management mould.  
The study of patient groups takes an interest in what social forces bring people together and how 
organisations can solidify that into action. One particular branch of STS that has developed a 
useful language for this process is Actor Network Theory (ANT) which is obscure to many 
academics and not without critics even within STS. For those that use ANT its benefits and 
disadvantages simultaneously come from its rich sociological and communications theory ideas 
and concepts and the myriad of terms Î sometimes duplicating and overlapping even within 
itself. From the ambiguities comes it strengths. For its critics those very same characteristics are 
its problems. Despite all this, the ideas emerged simply enough from the study of behaviours in a 
science lab in the 1970s (Latour and Woolgar 1986) and has generally been used in detailed case 
study contexts. Problematically, contained within ANT is an elegant language that describes the 
behaviours and strategies of players within environments that require complex networks to be 
developed before economic activity can be commenced. Although the originators of the ANT 
field object to its use for describing strategy there is a growing number who are using it in this 
way (see Neyland 2000). 
With this background, we think it is worth adopting what we want to call the Strategic-
Organisation variant of ANT (SO-ANT) which stripped down to bare essentials of the main core 
concepts can be applied in the current contexts. In this we are extending on a number of articles 
in the organisational studies and strategy fields and indeed even from within STS (see Neyland 
2000, Manning 2002, Sarker et.al. 2006 Steen et.al. 2006, Woolgar et.al.2009 etc etc.). Within 
our study we can align the key concepts of ANT with components of the system.  Our abridged 
SO-ANT structure emphasises the following concepts:  
 
Network construction terms - organisations 
‚ System Builder: In order to account for the heterogeneous activities of the people 
behind technological systems, Hughes employs this term to account for the 
management and interconnectedness of the entrepreneurial, financial, promotional, 
inventive, and lobbying efforts needed to build socio-technical systems. Like all other 
actors, system builders are constituted in the course of technology construction and the 
interaction with other actors. See Hughes 1979, 1983,1988; Law 1988; 
 In our analysis the charities are system builders Î constructing networks that 
benefit their donors. 
‚ Obligatory Passage Point (OPP): A product or effect of successful translation. Taken 
from military terminology, the location through which all enrolled actors must pass 
through. Understood in terms of power, forcing actors along certain paths and 
channels and barring access to others. See Callon 1986b; Law 1986b; Latour 1987, 
1988b, 1992; 
 In our analysis the charities are attempting to build systems that make them 
obligatory passage points for particular conditions.  
‚ Local/Global Network: Within ANT, an effect of negotiation strategies and processes 
between system builders and other actors in the (global) actor-network. The local actor 
network corresponds to the space where system builders have been granted relative 
autonomy. See Law & Callon 1988; Feenberg 1999; 
 The charities and foundations take on the role as a system builder Î organising 
events, corporate sponsorship on the one side and research system as best it can 
on the other. There is strong competition for donations and each charity is 
vt{kpi"vq"guvcdnkuj"kvugnh"cu"vjg"Òiq"vqÓ"qticpkucvkqp"pqv"lwuv"inqdcnn{"hqt"{qwt"
dollar but also in promoting a particular disease group. There can be 
competition between, by way of example, the Canadian Cancer Society which 
covers many cancers, the Canadian Breast Cancer Foundation and the Breast 
Cancer Society of Canada. Charities need to operate at all levels from 
grassroots social networks to collect donation through to natiopcn""ÒinqdcnÓ"
networks negotiating funding agreements with large corporations and research 
partnering agreements with national funding councils. 
Network construction Î aligning actor interests  
‚ Problematisation: the construction of the belief in society that certain problems are 
more important that others (see Callon, Law, and Rip 1986; Callon 1981); 
 The promotion that a particular disease and the current funding is a problem to 
be fixed. 
‚ Enrolment: A strategy by which actors, their roles, and their interests are defined 
through translation. An attempt to durably situate and fix actors in a sociotechnical 
network. Understood as a contingent process where success is never guaranteed. See 
Callon 1986b; Callon & Law 1982; Callon, Law & Rip 1986.; 
‚ Mobilisation: The attempts of system builders to oblige heterogeneous elements to 
gpcev"tqngu"cpf"rqukvkqpu"kp"vjg"u{uvgo"dwknfgtÓu"uqekqvgejpkecn"uegpctkq0"Ugg"cnuq"
sociotechnical scenario; translation; enrolment; juxtaposition. See Callon 1986b; Law 
1988; 
 The point of problematisation is to mobilise a group of people to become 
activists organising, collecting money, lobbying government.; 
Strategy making 
‚ Margin of Manoeuvre: An ambiguous potential inherent in the implementation of a 
dominant technical code. Corresponds to the potential actions and tactics of those 
charged with this implementation, that is, the actions and tactics unaccounted for by 
the system builders. See also translation; technical code; local/global network; 
program/anti-program symmetry. See Callon 1986b; Feenberg 1999, 2002. 
 The more crowded the space the charity dollar the harder it is for new 
organisations to grow. Unlike more conventional markets, it is not about new 
technologies it is about communicating that a particular cause has been 
underappreciated or under-funded.  
Italicised text is quoted from Cressman and Felczak 2009, various pages. 
We can then use each of these concepts to illustrate the processes observed in the way C&Fs 
have reconfigured the STI system. There are different steps and time lines through which these 
stages may occur for individual C&Fs, We have attempted to simplify the ideas to their core 
elements and a generalised version of the timeline.  But, to reiterate our focus is the strategy of 
the medical ejctkvkguÓ"gpicigogpv"ykvj"vjg"ockp"uekgpeg."vgejpqnqi{"cpf"kppqxcvkqp"u{uvgo"pqv"
how successful they are or their science impact; that must be left for a different paper. 
The public sphere Î from terra nullius to crowded space 
In the triple helix model as discussed earlier in this paper there is little or no discussion of the 
publicÓu"rtkqtkvkgu. It is the priorities of researchers, governments and business/markets that 
matter most. This is simplified into the view of Fig 3 which highlights the structuralist 
perspective as well as the fact that individuals or groups or individual make up these structures.   
 
Figure 3:  Triple Helix Model 
 
The public in this model is nowhere Î it is an empty domain. 
Problematisation 
In the newly emerging charities the public may appear to be organised by a formal institutional 
legal entity from the start but always it seems the process appears to commence small. A 
particular public comes to a realisation that its interests are not captured by the researcher or 
business oriented model and it wants those interests to be understood (Fig 4). This public realises 
that coalescing around its special interests of a particular diseases or conditions can be 
influential. This ÒproblematisationÓ process is twofold with the second part quite overt as can be 
understood from the significance that almost every large research charity in America, Australia, 
Canada and probably in most countries promote a version of the slogan Î Òresearch for a cureÓ3. 
Figure 4:  A patient group forms 
 
 
However, the only way research system prioritisation can be changed is through cash, and that 
only happens on a large scale through the emergence of a lead organisation.  
                                                 
3 So prominent has the word cure become that the Milken Institute Î a American non-profit think tank runs an 
cppwcn"gxgpv"ecnngf"ÐRctvpgtkpi"hqt"EwtguÑ0 
System builder emerges 
The administrative hub for a cause takes on the task or organising networks across multiple 
levels of society. Social networks must be built with the community and media and more formal 
links with business, government and the science establishment.  
Figure 5: System builder emerges 
 
Funding enrolment and mobilisation 
Large charities today do not only seek support of the community members across a country 
through word of mouth only, they run mass advertising campaigns such as that conducted for the 
Heart and Stroke Foundation of Canada (20124). This campaign with the tag line ÒDeath loves 
women. Make death waitÓ is simultaneously an endeavour at problematising the status quo with 
the assumption that breast cancer is the main killer of women and also enrolling more people to 
its cause. Alternatively, the charities can reach for corporate sponsorship or celebrity 
endorsement (causumerism - see King 2006 and Ponte and Riche 2011). For example the 
Canadian Breast Cancer event has a corporate brand attached. 
 
 
Source: Canadian Breast Cancer Foundation (2012) 
 
Researcher enrolment and mobilisation 
Not only do C&Fs seek to build a financial base through community support, that part of the 
community which suffers from a particular disease or condition forms a valuable resource of key 
stakeholders for researchers. Not only are they valuable as a group for influencing priority 
setting but they also provide for a pre-organised basis for clinical trials Î thus cutting down the 
costs and time for patient recruitment. 
                                                 
4 ÐFgcvj"Nqxgu"YqogpÑ"eqoogtekcn"ecp"dg"uggp"jgtg"http://vimeo.com/31387801 accessed 5 Feb 2013. 
The National Organization for Rare Diseases (NORD [USA]) clearly reveals this part of the 
C&F approach to the research system. NORD with its fragmented base of rare conditions could 
never hope to ictpgt" vjg" tgugctej" fqnnctu" qh" c" Òdtgcuv" ecpegtÓ" dwv" kv" ecp" nqdby government, 
provide money for patient assistance programs and start-up money for research. An organisation 
in the same space has taken a different strategy; RARE has created a data registry platform: 
The RARE Project is encouraging all families with RARE diseases to register with the ORP 
and to contribute their medical history and ongoing/daily medical experiences for the 
benefit of other families (including you!) and researchers. Every time you enter a piece of 
data into the ORP you will get a piece of information back Î usually in the form of a 
comparison of how your data compares to others with the same disease, symptoms, or 
therapies (RARE 2012). 
This growing database of patient information is of benefit to sufferers and in time will be 
invaluable to the research community. Self-organising communities around self-interest are 
aligned to promote research by making their data easier to access. The more accessible the data, 
the more likely the number of researchers in universities and companies will expand. 
C&Fs can also choose, if they are large enough to fund research directly or leverage the system 
through partnering with national granting councils. In 2010 we collected 10 examples of calls for 
research proposals in their own right issued by the charities to university researchers. In the cases 
of co-funding (see e.g. CIHR 2012) calls do not make clear the respective financial 
contributions5 of different charities, iqxgtpogpv"hwpfgf"Òpqp-rtqhkvuÓ6 and the Canadian 
Institutes of Health Research (CIHR is the federal granting council for health and medical 
research). All of the processes are less than clear but partnerships are the least clear of all. 
Alternatively, C&Fs can also go directly to the business community. The Michael J Fox 
Hqwpfcvkqp"*OLHH+"hqt"tgugctej"kpvq"RctmkpuqpÓu Disease based in the USA exemplifies this 
approach. Mumford (2011) states than in 11 years MJFF has spent US$265m in research of 
which $70m has gone to industry. Further, MJFF benefits with licencing revenues if the research 
continues.  
Finaly, the entire research system can be leveraged if there is political engagement. King (2006 
xv-xviii) provides the example of when President George Bush Sr decided not to support the 
transfer of $210m to breast cancer research, the issue became political with breast cancer groups 
campaigning for Bill Clinton. The National Cancer Institute budget rose from $155m in 1992 to 
$400m in 1993 Î with a significant amount of that increase dedicated to breast cancer. 
Thus the new system begins to look something like Fig 7. 
 
                                                 
5 The CIHR Institute of Infection and Immunity in partnership with the CIHR Institute of Circulatory and 
Respiratory Health, the CIHR Institute of Nutrition, Metabolism and Diabetes, The Kidney Foundation of Canada, 
Cystic Fibrosis Canada, Canadian Blood Services, and Genome British Columbia. 
6 For administrative reasons governments frequently create separate organisations to administer certain programs or 
near commercial activities. Often in Canada these are registered as non-profits although the majority of their funding 
is through government distribution. Based on the OECD Frascati Manual such organisations should not appear in the 
PNP statistics. Statistics Canada 2011 states, regarding PNPs,: Charitable foundations, voluntary health 
organizations, scientific and professional societies, and other organizations not established to earn profits comprise 
this sector. Private non-profit institutions primarily serving or controlled by another sector should be included in 
that sector (e.g., the Pulp and Paper Research Institute is in Canadian business enterprises). 
Figure 7: Charity funding model 
 
 
Manoeuvring in a crowded system 
While the C&F sphere is now a crowded space there are two in-determinates in the systems Î the 
total amount the public is willing to spend and the ability of new organisations to open up new 
niches. The most obvious example of a new cause is that of prostrate cancer. In recent years 
organisations modelling themselves explicitly on those in breast cancer have emerged (King 
2006 and Halebsky 2003). The most successful appears to have been Movember which 
commenced in 2003 in Australia with no money raised and 20 participants. In 2010 the global 
organisation raised $72m AUD, while in 2011 it raised $124 million AUD  from Australia, 
Belgium, Canada, Czech Republic, Denmark, Finland, Ireland, Netherlands, New Zealand, 
Norway, South Africa, Spain, UK and USA, with 854,288 ÒOq"Dtqu"("Oq"UkuvcuÓ"rctvkekrcvkpi"
in activities (Movember 2012); previously 1.1mill people had been involved cumulatively 
between 2003 and 2010 (Movember 2011). Clearly, the Movember campaign has found a place 
to grow. 
STI research system reconfiguration 
The charity and foundations as we have shown can exert influence on the STI systems as they 
gather public, corporate and philanthropic support. The goal of achieving this is not hidden. As 
one example the Muscular Dystrophy CanadaÓu"ygdukvg7 states: 
 Neuromuscular research was a driving reason for the formation of our organization 
in 1954. At that time little research was being done in Canada or elsewhere in the 
world. Our founder, Dr. David Green believed research was absolutely essential to 
our charitable missionÈÈ Today, our research program is based on partnerships 
with other organizations and individuals. Partnering allows Muscular Dystrophy 
Canada to leverage higher investments in research than we could afford acting 
independently.  
                                                 
7 http://www.muscle.ca/nc/national/research.html accessed 1 March 2010. 
For a huge variety of diseases and conditions there is now a new system to understand, a network 
of funding that co-organised by medical C&Fs, granting councils and business. The network 
stretches from individuals through to corporates to get funding and then funding is channelled 
through them to selected companies, government granting councils, academics and non-profit 
research labs. Many investigating the STI system have not understood this change in structure. 
There have always been obligatory passage points Î typically granting councils and these still 
exist and are important for the majority of the research system. However, in a limited number of 
cases it can be argued that the structure is shifting. 
Figure 8: The new system in special cases: charities as obligatory passage points (OPP) 
 
 
 
Despite this picture it is interesting to note that the charities themselves appear to feel left out8 of 
the dialogues on the STI system both at an academic and in high policy discussions. 
5. Discussion and Conclusions 
We started looking seriously at this topic when we began to understand role of environmental 
complexity in network performance (Wixted and Holbrook 2012) and the role that charities 
potentially play in reducing that complexity for particular fields of research. Our focus in this 
paper has been to highlight the fact that charities and foundations (C&Fs) have been consistently 
ignored in the main literature on the science, technology and innovation (STI) systems and 
further to make clear that their funding is significant. Lastly, our emphasis is on the strategy of 
                                                 
8 Private conversations.. They have formed a peak association the Health Charities Coalition of Canada 
http://www.healthcharities.ca/ accessed 05-02-2013 which itself has become part of a larger lobbying effort 
Research 7 http://www.acaho.org/?document&id=339 accessed 05-02-2013. 
the medical E(HuÓ engagement with the STI systems not how successful they have been or their 
science impact. 
Governments increasingly feel the need to justify research expenditures through research 
evaluation and impact assessments but this work remains disconnected from engaging with the 
rwdnkeÓu"kpvgtguvu0"Vjg"rwdnke"pqv"qpn{"rc{u"vczgu"hqt"tgugctej"dwv"kp"ocp{"eqwpvtkgu engages in 
direct democracy voting through cash in the hand for research of its own choosing. This form of 
science prioritisation is little explored and under appreciated. Part of the challenge to 
understanding the system better lies in the fact that the data framework is outdated.  
In this paper we have shown that in a number of OECD countries charities are a bigger funder of 
research in universities than businesses yet the literature is devoted to the relationships between 
business, government and universities. The public has clearly felt that its interests have been 
ignored and have developed new pathways to researchers and influencing priorities. In this paper 
we have also attempted to show how C&Fs are able to form complex networks of mass 
participation, university researchers, corporate and government interests. The SO-ANT 
framework employed here we believe is useful for highlighting key activities of the medical 
C&Fs. While there has been cp" cpcn{vkecn" vwtp" kp" vjg" uqekcn" uekgpegu" vqyctfu" ÒpgvyqtmuÓ"
(Borgartti et.al. 2009), there is little room for the actor in such structural analysis (see Kilduff 
and Bass). There is room therefore for an actor centric approach to network construction and the 
SO-ANT approach is an early attempt at filling this need. 
Yet, the questions which remain are huge. At the national level; how can policy makers in 
government and universities more openly discuss the Òuekgpeg" hwpfkpi"octmgvÓ? Does the SO-
ANT framework work for non-medical PNPs in the research system? We do not have a useful 
taxonomy of PNP organisations and their expenditure. We do not have data on medical research 
by medical conditions so that a comparison of disease likelihood and funding is simple and 
accessible. The accounts of charities while public are not systematically reviewed. Science 
policy, communications theory and organisational strategy are all part of understanding the 
complex world of the PNPs in the broader science and technology system. C&Fs employ 
sophisticated communication practices, using the most recent developments in new media such 
as social networking, and new communication technologies. These campaigns reach a 
completely new generation of potential donors. No longer, it seems, are most donors 
economically successful individuals who have large funds they can donate, but, now, the vast 
majority of fund-raising campaigns focus on raising funds through small donations from the 
largest possible number of citizens. The process has become mass-marketed and ÒdemocratizedÓ.  
This is a brave new world for the research establishment, who to date, have never really had to 
worry about public opinion.  
Finally, while medical research is the major recipient of the funding from PNPs what impact 
does this have on the rest of the research system? Business in general may lobby on behalf of 
some of the natural sciences, including health but what voice is there then for the environment 
and social sciences research? 
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